Sebaceous carcinoma presenting as chronic chalazion

We present a case of sebaceous carcinoma presenting as treatment-resistant chalazion. Diagnosis was made by excisional biopsy after failed treatment with warm compresses, eyelid hygiene and erythromycin ointment. Conjunctival map biopsies excluded local spread. MRI of the orbits and whole-body positron emission tomography demonstrated no metastatic disease. Definitive treatment was accomplished by wide local excision with no recurrence at 1-year follow-up. Sebaceous carcinoma often masquerades as benign diagnoses, such as blepharitis and chalazion, yet it is an aggressive cancer with high rates of morbidity and mortality. Thus, a high level of suspicion is required to avoid vision loss and death by metastatic disease. There are currently no targeted therapies for advanced disease, highlighting the importance of prompt diagnosis. Furthermore, recognition of the association of sebaceous carcinoma with Muir-Torre Syndrome is important to guide future cancer screening and management.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2025-03-01
DOI
https://doi.org/10.1136/bcr-2023-258895
Primary Topic
Nonmelanoma Skin Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sebaceous carcinoma presenting as chronic chalazion

Preeti J. Thyparampil, Paul J. Bryar, Madeline Arzbecker
BMJ Case Reports
Nonmelanoma Skin Cancer Studies
article

Sebaceous carcinoma presenting as chronic chalazion

Preeti J. Thyparampil, Paul J. Bryar, Madeline Arzbecker
article en

Abstract

We present a case of sebaceous carcinoma presenting as treatment-resistant chalazion. Diagnosis was made by excisional biopsy after failed treatment with warm compresses, eyelid hygiene and erythromycin ointment. Conjunctival map biopsies excluded local spread. MRI of the orbits and whole-body positron emission tomography demonstrated no metastatic disease. Definitive treatment was accomplished by wide local excision with no recurrence at 1-year follow-up. Sebaceous carcinoma often masquerades as benign diagnoses, such as blepharitis and chalazion, yet it is an aggressive cancer with high rates of morbidity and mortality. Thus, a high level of suspicion is required to avoid vision loss and death by metastatic disease. There are currently no targeted therapies for advanced disease, highlighting the importance of prompt diagnosis. Furthermore, recognition of the association of sebaceous carcinoma with Muir-Torre Syndrome is important to guide future cancer screening and management.

BMJ Case ReportsVol. 18(3)
Northwestern University (US), University of Wisconsin–Madison (US)
Research to Prevent Blindness
Good health and well-being
Openalex Percentile: Top 93%
Nonmelanoma Skin Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.